Targeting hepatocyte-derived LRG1 with dothiortone alleviates hepatic ischemia–reperfusion injury and remote renal damage via suppressing NETosis
Changlin Du, Zhenming Zhang, Jiali Wang, Zhaokun Li, Zhenlong Liu, Yan Zhu, Jipeng Cheng, Wenna Meng, Zhiying Yang, Na Cai, Zhongnan Zhou, Lu Chen, Jingwen Zhang, Hui Jiang, Yan Chen, Cheng Huang, Jun Li, Taotao Ma Experimental & Molecular Medicine
· Springer Nature
· 2026-11-05
· DOI: 10.1038/s12276-026-01882-1
Abstract
Experimental & Molecular Medicine, Published online: 05 November 2026; doi:10.1038/s12276-026-01882-1 Hepatic ischemia–reperfusion injury (HIRI) poses significant challenges in liver surgery and transplantation owing to oxidative stress and inflammation, leading to liver and remote organ damage, such as acute kidney injury. This study identifies leucine-rich α-2 glycoprotein 1 (LRG1) as a key player in exacerbating HIRI by promoting neutrophil extracellular trap (NET) formation, which triggers apoptosis in liver cells and contributes to kidney damage. Researchers used hepatocyte-specific Lrg1-knockout mice and found that LRG1 deficiency reduced liver injury and apoptosis, highlighting the ro
Changlin Du, Zhenming Zhang, Jiali Wang, Zhaokun Li, Zhenlong Liu, Yan Zhu et al. Targeting hepatocyte-derived LRG1 with dothiortone alleviates hepatic ischemia–reperfusion injury and remote renal damage via suppressing NETosis. // Experimental & Molecular Medicine. – 2026. – DOI: 10.1038/s12276-026-01882-1. – URL: https://www.nature.com/articles/s12276-026-01882-1
Changlin Du, Zhenming Zhang, Jiali Wang, Zhaokun Li, Zhenlong Liu, Yan Zhu, Jipeng Cheng, Wenna Meng, Zhiying Yang, Na Cai, Zhongnan Zhou, Lu Chen, Jingwen Zhang, Hui Jiang, Yan Chen, Cheng Huang, Jun Li, & Taotao Ma (2026). Targeting hepatocyte-derived LRG1 with dothiortone alleviates hepatic ischemia–reperfusion injury and remote renal damage via suppressing NETosis. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01882-1
Changlin Du, et al. “Targeting hepatocyte-derived LRG1 with dothiortone alleviates hepatic ischemia–reperfusion injury and remote renal damage via suppressing NETosis.” Experimental & Molecular Medicine, 2026. doi:10.1038/s12276-026-01882-1.
@article{Du2026,
title = {Targeting hepatocyte-derived LRG1 with dothiortone alleviates hepatic ischemia–reperfusion injury and remote renal damage via suppressing NETosis},
author = {Du, Changlin and Zhang, Zhenming and Wang, Jiali and Li, Zhaokun and Liu, Zhenlong and Zhu, Yan and Cheng, Jipeng and Meng, Wenna and Yang, Zhiying and Cai, Na and Zhou, Zhongnan and Chen, Lu and Zhang, Jingwen and Jiang, Hui and Chen, Yan and Huang, Cheng and Li, Jun and Ma, Taotao},
journal = {Experimental \& Molecular Medicine},
year = {2026},
doi = {10.1038/s12276-026-01882-1},
url = {https://www.nature.com/articles/s12276-026-01882-1}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’